619 Durvalumab Plus Carboplatin/paclitaxel Followed by Durvalumab ± Olaparib As a First-Line Treatment for Newly Diagnosed Advanced or Recurrent Endometrial Cancer: Results from the Phase III DUO-E/GOG-3041/ENGOT-EN10 Trial Shannon N. Westin, Kathleen N. Moore,Hye Sook Chon,Jung‐Yun Lee,Jessica Thomes Pepin, Michael J. Sundborg,Joseph de la Garza,Shin Nishio, Ke Wang,Kristi McIntyre,Todd Tillmanns,Fernando Contreras Mejía, Andréia Cristina de Melo, Dagmara Klasa-Mazurkewicz, Christos Papadimitriou,Marta Gil-Martín,Birutė Brasiūnienė, Conor Donnelly,Xiaochun Liu,Els Van Nieuwenhuysenopenalex（2024）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
